Back to search
Relapsing or Refractory Multiple Sclerosis (MS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Relapsing or Refractory Multiple Sclerosis (MS) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Relapsing or Refractory Multiple Sclerosis (MS) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolera…
This single-arm, open-label investigator-initiated trial (IIT) evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of RD06-05 i…